KAL1 Antikörper (AA 384-680)
Kurzübersicht für KAL1 Antikörper (AA 384-680) (ABIN7855662)
Target
Alle KAL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 384-680
-
Verwendungszweck
- Mouse Anti-KAL1 (Anosmin 1) monoclonal antibody, clone PA343-13.22.2
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- Human Anosmin 1 (KAL1) partial (aa 384 to 680) recombinant protein 6xHis tagged, produced in E. coli
-
Isotyp
- IgG1
-
-
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 200-300) antibody
KAL1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) antibodyKAL1 Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2E8 unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 166-194), (N-Term) antibodyKAL1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB39497 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 5.0 mg/mL
-
Buffer
- 5.0 mg/mL solution in Phosphate-Buffered Saline (PBS). No preservatives added
-
Konservierungsmittel
- Without preservative
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C (long term storage)
-
-
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
-
Andere Bezeichnung
- KAL1
-
Hintergrund
- Kallmann Syndrome Interval Gene 1, KALIG1, Adhesion molecule-like, X-Linked, ADMLX, HH1, HHAKMS, WFDC19
-
NCBI Accession
- NM_000216
-
OMIM
- 300836
Target
-
